Study S002820

Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07144098
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 24
Start: 2025-08-12
Primary completion: 2026-07-12
Lead sponsor: Gan & Lee Pharmaceuticals.
Conditions: Obesity/Overweight
Interventions: DRUG:GZR18 injection
Results posted: FALSE

Registered primary outcomes

Cmax:Maximum plasma concentration. [through study completion, an average of 36 days]
AUC0-last:Area under the plasma concentration-time curve at 0 h to last observation time-point after a single dose. [through study completion, an average of 36 days]
AUC0-inf:Area under the plasma concentration-time curve at 0 h to infinity after a single dose. [through study completion, an average of 36 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.